EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Post-bariatric hypoglycaemia: from altered gut physiology to targeted therapies

Wei Yang iD, Tricia M-M Tan

Endocrine Connections · 01.08.2026 · 15 (8)

DOI: 10.1530/ec-25-0850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Connections, online erschienen am 29.06.2026. Verfasst von Wei Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College Lond…. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-bariatric hypoglycaemia (PBH) is an increasingly recognised complication of bariatric and metabolic surgery, which can markedly impair quality of life and jeopardise the long-term benefits of surgery. This review summarises the current evidence on the epidemiology, pathophysiology, and management of PBH, with a particular focus on mechanism-based treatment strategies. We first point out the limitations of existing epidemiological data and then outline a practical diagnostic framework. We next review the evolving understanding of PBH as a heterogeneous, pathophysiology-driven syndrome arising from rapid nutrient delivery, exaggerated incretin responses, excessive insulin secretion, impaired glucagon secretion, and emerging contributors, such as postprandial serotonin hypersecretion, bile acid signalling, and microbiome change. On this basis, we review therapeutic options by mechanistic target, covering dietary and lifestyle interventions, acarbose, SGLT inhibition, somatostatin analogues, GLP-1 receptor antagonists, diazoxide, glucagon-based approaches, and experimental serotonin receptor antagonism, and briefly discuss agents with limited supportive evidence. Finally, we explore key knowledge gaps and future directions, including the need for long-term prospective data, precision medicine approaches, rational combination therapy, and greater integration of continuous glucose monitoring and digital decision support. Mechanism-based, multidisciplinary care from bariatric physicians, dietitians, and surgeons offers the best prospect of managing PBH, preserving quality of life, and safeguarding the metabolic benefits of bariatric surgery.

Schlagwörter

Stichwörter der Autor:innen

bariatric surgerymechanismobesityphysiologypost-bariatric hypoglycaemiatreatment

Autor:innen und Institutionen

  • Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London , London, UK.

ORCID-Profile: Wei Yang

Zitieren

APA

Yang, W., & Tan, T. M. (2026). Post-bariatric hypoglycaemia: from altered gut physiology to targeted therapies. Endocrine Connections, 15(8). https://doi.org/10.1530/ec-25-0850

Vancouver

Yang W, Tan TM. Post-bariatric hypoglycaemia: from altered gut physiology to targeted therapies. Endocrine Connections. 2026;15(8). doi:10.1530/ec-25-0850

BibTeX
@article{Yang2026,
  author = {Yang, Wei and Tan, Tricia M-M},
  title = {Post-bariatric hypoglycaemia: from altered gut physiology to targeted therapies},
  journal = {Endocrine Connections},
  year = {2026},
  volume = {15},
  number = {8},
  doi = {10.1530/ec-25-0850}
}
Kostenlos starten →